tooluniverse-binder-discovery
Discover novel small molecule binders for protein targets using structure-based and ligand-based approaches. Creates actionable reports with candidate compounds, ADMET profiles, and synthesis feasibility. Use when users ask to find small molecules for a target, identify novel binders, perform virtual screening, or need hit-to-lead compound identification.
npx skills add FreedomIntelligence/OpenClaw-Medical-Skills --skill tooluniverse-binder-discovery --agent claude-code
Same command for any agent — swap --agent for codex, cursor, copilot.
Weekly change comes from our own snapshots, not the repository page — it measures attention, not adoption.
What it does
The skill systematically discovers novel small molecule binders for a protein target by combining structure-based and ligand-based approaches across druggability assessment, known ligand mining, similarity expansion, ADMET filtering, and synthesis feasibility. It emphasizes a report-first workflow that creates a binder discovery report file first, then progressively updates it with findings, and outputs separate data files for prioritized candidates and literature references.
How it works
- It follows a multi-stage workflow starting with Phase 0 Tool Verification to check parameters for tools like ChEMBL_get_target_activities.
- Phase 1 Target Validation performs identifier resolution, drudgability assessment, binding-site identification, and structure prediction where needed, including GPCR-specific enrichment and optional antibody landscape checks via Thera-SAbDab.
- Phase 2 Known Ligand Mining gathers bioactivity data from ChEMBL, ligand interactions from GtoPdb, chemical probes from OpenTargets, and SAR/actives analysis, with outputs embedded into the report.
- Phase 3 Structure Analysis retrieves PDB structures, assesses binding sites, and analyzes domain architecture via InterPro data.
- Phase 4 Compound Expansion explores similar structures and performs de novo generation when appropriate.
- Phase 5 ADMET Filtering predicts properties and flags liabilities.
- Phase 6 Candidate Docking & Prioritization docks candidates, scores by docking/ADMET/novelty, assesses synthesis feasibility, and generates a final ranked list.
- Phase 7 Report Synthesis consolidates the results into the final report. The system maintains a strict report-first approach, creating a file named
[TARGET]_binder_discovery_report.mdwith placeholder sections, then filling them progressively.
When to use it
Use when users ask to find small molecules for a target, identify novel binders, perform virtual screening, or need hit-to-lead compound identification.
What it can touch
- Tool names referenced include:
ChEMBL_get_target_activities,NVIDIA_API_KEYis required for NVIDIA NIM actions, and tools likeNvidiaNIM_alphafold2,NvidiaNIM_esmfoldmay be invoked for structure prediction. The workflow specifies creating and updating files such as[TARGET]_binder_discovery_report.md,[TARGET]_candidate_compounds.csv, and[TARGET]_bibliography.jsonas output artifacts.
Caveats
- The workflow relies on environment and tool availability (e.g., NVIDIA NIM and API keys) and requires careful phase transitions to maintain the report-first discipline. No outcomes are guaranteed; results depend on input data and tool responses. The approach includes explicit reporting formats and source citations in the report sections.
# Small Molecule Binder Discovery Strategy Systematic discovery of novel small molecule binders using 60+ ToolUniverse tools across druggability assessment, known ligand mining, similarity expansion, ADMET filtering, and synthesis feasibility. **KEY PRINCIPLES**: 1. **Report-first approach** - Create report file FIRST, then populate progressively 2. **Target validation FIRST** - Confirm druggability before compound searching 3. **Multi-strategy approach** - Combine structure-based and ligand-based methods 4. **ADMET-aware filtering** - Eliminate poor compounds early 5. **Evidence grading** - Grade candidates by supporting evidence 6. **Actionable output** - Provide prioritized candidates with rationale 7. **English-first queries** - Always use English terms in tool calls, even if the user writes in another language. Only try original-language terms as a fallback. Respond in the user's language --- ## Critical Workflow Requirements ### 1. Report-First Approach (MANDATORY) **DO NOT** show search process or tool outputs to the user. Instead: 1. **Create the report file FIRST** - Before any data collection: - File name: `[TARGET]_binder_discovery_report.md` - Initialize with all sectio
- Critical Workflow Requirements
- 1. Report-First Approach (MANDATORY)
- 2. Citation Requirements (MANDATORY)
- Workflow Overview
- Phase 0: Tool Verification
- Known Parameter Corrections
- Phase 1: Target Validation
- 1.1 Identifier Resolution Chain
- 1.2 Druggability Assessment
- 1.2a GPCRdb Integration (NEW - for GPCR Targets)
- 1.2.5 Therapeutic Antibody Landscape (NEW)
- 1.3 Binding Site Analysis
- 1.4 Structure Prediction (NVIDIA NIM)
- Phase 2: Known Ligand Mining
What does the tooluniverse-binder-discovery skill do?
Discover novel small molecule binders for protein targets using structure-based and ligand-based approaches. Creates actionable reports with candidate compounds, ADMET profiles, and synthesis feasibility. Use when users ask to find small molecules for a target, identify novel binders, perform virtual screening, or need hit-to-lead compound identification.
How do I install it?
Run `npx skills add FreedomIntelligence/OpenClaw-Medical-Skills --skill tooluniverse-binder-discovery --agent claude-code` — it drops the skill into your project so the agent can pick it up. Swap the --agent value for codex, cursor or copilot if you use one of those.
Where does this skill come from?
From FreedomIntelligence/OpenClaw-Medical-Skills, a repository with 2,909 stars. We read it straight from the repository tree rather than a submitted listing, so what you see here is what is actually published.
Is a popular skill a good skill?
Not necessarily. Stars measure attention, not adoption — a repository can trend for a week and be abandoned. That is why we show the weekly change from our own snapshots next to the total, instead of a single flattering number.
